ArticleKidney international reports2026
Correlates of Pretransplant Outcomes in United States Kidney Transplant Programs, 2015 to 2020.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Metrics That Matter: Evaluating the Correlates of Pretransplant Performance in US Kidney Transplant Programs.Kidney international reports · 2026Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
Introduction: Increasing access to kidney transplantation for patients with end-stage renal disease is a high priority in the United States. Recent policy changes to promote this include establishment of performance metrics examining the pretransplant performance of kidney transplant programs, but little is known about transplant program practices associated with these performance metrics. Our goal is to characterize waitlist attributes associated with the newly established pretransplant performance metrics at adult kidney transplant programs. Methods: We conducted a retrospective cohort analysis using completed case national data from the Scientific Registry of Transplant Recipients (SRTR). Exposures included deceased donor kidney waitlist attributes such as waitlist prevalence, waitlist incidence, percentage of incidence patients who are made status active, and transplant priority scores at key points including activation. Outcomes included pretransplant mortality rate ratio (PMRR) and organ acceptance rate ratio (OARR), as defined by the Organ Procurement Transplant Network (OPTN) Membership and Professional Standards Committee, for each transplant program-year. Results: Our study included 1268 transplant program-years from 2015 to 2020, representing 220 unique adult kidney transplant programs. Higher offer acceptance was associated with fewer patients on the waitlist (1.4% increase per every 100-patient decrease) and a higher percentage of patients receiving an offer within 90 days of activation (24.0% increase per 10% increase in the percent of patients receiving offers). Lower pretransplant mortality was associated with fewer patients on the waitlist (1.4% decrease per 100-patient decrease). Conclusion: A larger waitlist was associated with both higher pretransplant mortality and lower offer acceptance. Transplant programs behaviors underlying waitlist attributes associated with better or worse outcomes warrant additional investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.